CRP and hepatocellular carcinoma: Studies conducted by Shimizu et al. [41] and Ren et al. [42] showed that a high pre-treatment serum CRP/ALB ratio independently predicted worse OS and tumor-free survival (TFS) in HCC patients undergoing curative surgical resection.